-
公开(公告)号:US5071749A
公开(公告)日:1991-12-10
申请号:US174449
申请日:1988-03-25
申请人: Eiji Kondo , Yoshimi Kawamura , Naoki Tsuji , Koichi Matsumoto , Masaaki Kobayashi , Toshiyuki Kamigauchi , Yoshiyuki Hayashi , Takao Konishi
发明人: Eiji Kondo , Yoshimi Kawamura , Naoki Tsuji , Koichi Matsumoto , Masaaki Kobayashi , Toshiyuki Kamigauchi , Yoshiyuki Hayashi , Takao Konishi
CPC分类号: C07K9/008
摘要: Glycopeptide antibiotics PA-45052 which are produced by Nocardia orientalis PA-45052, show potent activity against gram-positive bacteria, especially against methicillin-resistant bacteria, and stimulate growth of animals.
-
公开(公告)号:US4647693A
公开(公告)日:1987-03-03
申请号:US719737
申请日:1985-04-03
申请人: Eiji Kondo , Yoshimi Kawamura , Takao Konishi , Koichi Matsumoto , Junichi Shoji
发明人: Eiji Kondo , Yoshimi Kawamura , Takao Konishi , Koichi Matsumoto , Junichi Shoji
IPC分类号: C07G11/00 , A61K31/195 , A61P31/04 , C07C279/14 , C07K5/06 , C07K5/065 , C07K14/195 , C07K14/41 , C12P1/06 , C12P13/02 , C12P21/02 , C12R1/625 , C07C101/34
CPC分类号: C12R1/625 , C07K5/06078
摘要: Antibiotics DO-248-A and DO-248-B of the following Formula I: ##STR1## wherein R is ethyl or isopropyl, have antibacterial activity against acid-fast bacteria. DO-248-A, DO-248-B, or their pharmaceutically acceptable salts are, as an active ingredient of anti-fast-acid drugs, orally or parenterally administered to human beings or animal. DO-248-A and DO-248-B are prepared by incubating an antibiotic DO-248-A- and/or DO-248-B-producing microorganism belonging to genus Streptoverticillium in a medium and recovering antibiotic DO-248-A and/or DO-248-B from the culture broth.
摘要翻译: 具有下式I的抗生素DO-248-A和DO-248-B:其中R是乙基或异丙基,具有抗酸性细菌的抗菌活性。 DO-248-A,DO-248-B或其药学上可接受的盐作为抗快速药物的活性成分,口服或肠胃外给予人或动物。 通过在培养基中温育属于链霉菌属(Streptoverticillium)的抗生素DO-248-A和/或DO-248-B的微生物并回收抗生素DO-248-A和 /或DO-248-B。
-
公开(公告)号:US4946941A
公开(公告)日:1990-08-07
申请号:US3252
申请日:1987-01-14
申请人: Eiji Kondo , Naoki Tsuji , Koichi Matsumoto , Yoshimi Kawamura , Tadashi Yoshida , Shinzo Matsuura
发明人: Eiji Kondo , Naoki Tsuji , Koichi Matsumoto , Yoshimi Kawamura , Tadashi Yoshida , Shinzo Matsuura
摘要: The compounds of the formula: ##STR1## wherein R is ##STR2## or H, wherein X is NH.sub.2 and Y is CH.sub.3 ; or X is OH and Y is H, and their pharmaceutically acceptable salts. The compounds have a potent activity against gram-positive bacteria, especially, methicillin-resistant bacteria.
摘要翻译: 下式的化合物:其中R是H,其中X是NH 2,Y是CH 3; 或X为OH且Y为H及其药学上可接受的盐。 这些化合物对革兰氏阳性细菌,特别是耐甲氧西林细菌具有很强的活性。
-
公开(公告)号:US4371617A
公开(公告)日:1983-02-01
申请号:US244857
申请日:1981-03-18
申请人: Kentaro Tanaka , Naoki Tsuji , Eiji Kondo , Yoshimi Kawamura
发明人: Kentaro Tanaka , Naoki Tsuji , Eiji Kondo , Yoshimi Kawamura
CPC分类号: C12R1/465 , C12P17/184 , Y10S435/886
摘要: A new process for preparing thienamycin, a known antibiotic useful as a medicament and veterinary drug, characterized by cultivating Streptomyces penemifaciens sp. nov. in a suitable medium and recovering thienamycin from the fermentation broth.
摘要翻译: 一种制备硫辛霉素的新方法,已知的可用作药物和兽药的抗生素,其特征在于培养长链短杆菌(Streptomyces penemifaciens sp。 nov。 在合适的培养基中并从发酵液中回收噻吩霉素。
-
公开(公告)号:US4448723A
公开(公告)日:1984-05-15
申请号:US432102
申请日:1982-09-29
申请人: Kentaro Tanaka , Eiji Kondo , Mikao Mayama , Kouichi Matsumoto , Yoshimi Kawamura , Naoki Tsuji
发明人: Kentaro Tanaka , Eiji Kondo , Mikao Mayama , Kouichi Matsumoto , Yoshimi Kawamura , Naoki Tsuji
IPC分类号: C07D477/00 , A61K31/397 , A61K31/40 , A61P31/04 , C07D477/20 , C12P1/06 , C12P17/18 , C12R1/465 , C07D487/04
CPC分类号: C07D477/20 , C12P17/184
摘要: New antibiotics having .beta.-lactamase inhibitory activity, PA-41746-B and C of the formula ##STR1## wherein R is carboxymethylsulfinyl (PA-41746-B) or formylsulfinyl (PA-41746-C) and the pharmaceutically acceptable salts being useful as a medicament, a veterinary drug and a disinfectant for inhibiting the growth of gram-positive and gram-negative pathogenic microorganisms and a process for preparing the same, being characterized by cultivating Streptomyces pluracidomyceticus in a suitable medium and isolating PA-41746-B and/or PA-41746-C from the culture broth.
摘要翻译: 具有β-内酰胺酶抑制活性的新抗生素,式为IMA IMA的PA-41746-B和C,其中R为羧甲基亚磺酰基(PA-41746-B)或甲酰亚磺酰基(PA-41746-C),其药学上可接受的盐可用作 用于抑制革兰氏阳性和革兰氏阴性病原微生物生长的药物,兽药和消毒剂及其制备方法,其特征在于在合适的培养基中培养链霉菌(Streptomyces pluracidomyceticus)并分离PA-41746-B和/ 或来自培养液的PA-41746-C。
-
公开(公告)号:US4292241A
公开(公告)日:1981-09-29
申请号:US115278
申请日:1980-01-25
申请人: Kentaro Tanaka , Jun'ichi Shoji , Yoshimi Kawamura , Teruo Hattori , Eiji Kondo , Kouichi Matsumoto , Tadashi Yoshida , Naoki Tsuji
发明人: Kentaro Tanaka , Jun'ichi Shoji , Yoshimi Kawamura , Teruo Hattori , Eiji Kondo , Kouichi Matsumoto , Tadashi Yoshida , Naoki Tsuji
IPC分类号: C07D477/00 , A61K31/397 , A61K31/40 , A61P31/04 , C07D477/20 , C07D487/04 , C12P17/18 , C12R1/465
CPC分类号: C07D477/20 , C12P17/184 , C12R1/465
摘要: A new antibiotic having .beta.-lactamase inhibitory activity, PA-31088-IV, being useful as a medicament and a veterinary drug for inhibiting the growth of gram-positive and gram-negative phathogenic microorganisms and a process for preparing the same, being characterized by cultivating Streptomyces tokunonensis sp. nov. in a suitable medium and recovering PA-31088-IV from the cultured broth.
摘要翻译: 具有β-内酰胺酶抑制活性的新型抗生素PA-31088-IV可用作药物和用于抑制革兰氏阳性和革兰氏阴性致病微生物生长的兽药及其制备方法,其特征在于 培养链霉菌(Toreptomyces tokunonensis sp。) nov。 在合适的培养基中回收PA-31088-IV。
-
公开(公告)号:US4950686A
公开(公告)日:1990-08-21
申请号:US86583
申请日:1987-08-18
申请人: Eiji Kondo , Yoshiyuki Hayashi , Takao Konishi , Teruo Hattori , Junichi Shoji
发明人: Eiji Kondo , Yoshiyuki Hayashi , Takao Konishi , Teruo Hattori , Junichi Shoji
IPC分类号: C07C49/753 , A61K31/12 , A61K31/19 , A61K31/215 , A61K31/22 , A61K31/255 , A61K31/26 , A61K31/335 , A61K31/34 , A61K31/343 , A61K31/357 , A61P31/04 , A61P33/02 , C07C45/00 , C07C49/717 , C07C51/00 , C07C59/125 , C07C67/00 , C07C69/28 , C07C69/67 , C07C69/68 , C07C301/00 , C07C309/72 , C07C325/00 , C07C331/06 , C07D307/89 , C07D317/22 , C07F15/02 , C07F15/04 , C07F15/06
CPC分类号: A61K31/12 , A61K31/215 , A61K31/22 , A61K31/255 , A61K31/26 , A61K31/335 , A61K31/34
摘要: An anti-mycoplasma agent comprising tropolone, its derivatives, represented by the formula: ##STR1## (wherein R.sub.1 is hydroxy, aliphatic acyloxy, arylacyloxy, arysulfonyloxy, carboxyalkyloxy or its ester, benzoylalkyloxy, alkenyloxy, 1,3-dihydro-3-oxo-1-isobenzofuranyloxy, (2-oxo-5-methyl-1,3-dioxol-4-yl)methyloxy or thiocyanato and R.sub.2 is hydrogen, halogen, hydroxy, alkyl or alkoxy) and their salts as an active ingredient, which has potent activity especially against tylosin-resistant mycoplasma both in vitro and in vivo and is effectively used in treating the diseases caused thereby.
摘要翻译: 一种抗支原体药,其包含由下式表示的托普洛芬及其衍生物:其中R1是羟基,脂族酰氧基,芳基酰氧基,芳磺酰氧基,羧基烷氧基或其酯,苯甲酰基烷氧基,烯氧基,1,3-二氢-3-氧代 -1-异苯并呋喃基氧基,(2-氧代-5-甲基-1,3-间二氧杂环戊烯-4-基)甲氧基或硫氰酸酯,R 2为氢,卤素,羟基,烷基或烷氧基)及其盐作为活性成分, 特别是在体外和体内抗泰乐菌素抗性支原体的有效活性,并且有效地用于治疗由此引起的疾病。
-
公开(公告)号:US4456686A
公开(公告)日:1984-06-26
申请号:US421580
申请日:1982-09-22
申请人: Kentaro Tanaka , Eiji Kondo , Kouichi Matsumoto , Jun'ichi Shoji , Naoki Tsuji
发明人: Kentaro Tanaka , Eiji Kondo , Kouichi Matsumoto , Jun'ichi Shoji , Naoki Tsuji
IPC分类号: C07D477/00 , A61K31/397 , A61K31/40 , A61P31/04 , C07D477/20 , C12P17/18 , C12R1/465
CPC分类号: C07D477/20 , C12P17/184 , C12R1/465 , Y10S435/886
摘要: A new antibiotic having .beta.-lactamase inhibitory activity, PA-39504-X.sub.1 of the formula: ##STR1## being useful as a medicament and a veterinary drug for inhibiting the growth of gram-positive and gram-negative pathogenic microorganisms and a process for preparing the same, being characterized by cultivating Streptomyces argenteolus PA-39504 or Streptomyces tokunonensis PA-31088 in a suitable medium and recovering PA-39504-X.sub.1 from the cultured broth.
-
公开(公告)号:US4387052A
公开(公告)日:1983-06-07
申请号:US286757
申请日:1981-07-27
申请人: Kentaro Tanaka , Eiji Kondo , Kouichi Matsumoto , Jun'ichi Shoji , Naoki Tsuji
发明人: Kentaro Tanaka , Eiji Kondo , Kouichi Matsumoto , Jun'ichi Shoji , Naoki Tsuji
IPC分类号: C07D477/00 , A61K31/397 , A61K31/40 , A61P31/04 , C07D477/20 , C12P17/18 , C12R1/465 , C07D487/04
CPC分类号: C07D477/20 , C12P17/184
摘要: A new antibiotic having .beta.-lactamase inhibitory activity, PA-39504-X.sub.3 of the formula: ##STR1## and the pharmaceutically acceptable slats being useful as a drug, a animal drug and a disinfectant for inhibiting the growth of gram-positive and gram-negative pathogenic microorganisms and a process for preparing the same, being characterized by cultivating Streptomyces argenteolus PA-39504 or Streptomyces tokunonensis PA-31088 in a suitable medium and isolating PA-39504-X.sub.3 from the cultured broth.
摘要翻译: 具有β-内酰胺酶抑制活性的新型抗生素,下式的PA-39504-X3:药物可接受的片剂可用作药物,动物药物和用于抑制革兰氏阳性和革兰氏阳性菌生长的消毒剂, 阴性致病微生物及其制备方法,其特征在于在合适的培养基中培养棒状链霉菌PA-39504或链霉菌Tokunonensis PA-31088,并从培养液中分离PA-39504-X3。
-
公开(公告)号:US4647408A
公开(公告)日:1987-03-03
申请号:US574362
申请日:1984-01-27
申请人: Kentaro Tanaka , Eiji Kondo , Kouichi Matsumoto , Naoki Tsuji
发明人: Kentaro Tanaka , Eiji Kondo , Kouichi Matsumoto , Naoki Tsuji
IPC分类号: C07D477/20 , C12P17/18 , C07D487/04 , A61K31/40
CPC分类号: C12P17/184 , C07D477/20
摘要: Antibiotics PA-41746-A.sub.2, PA-41746-E and PA-41746-F produced by fermentation of Streptomyces pluracidomyceticus on a conventional culture medium, having .beta.-lactamase inhibitory activities and excellent antimicrobial activities, and useful as drugs for treatment of infections in humans or animals, or as disinfectants.
摘要翻译: 抗生素PA-41746-A2,PA-41746-E和PA-41746-F,其通过在常规培养基上发酵链霉菌(Plrepacidomyceticus)产生,具有β-内酰胺酶抑制活性和优异的抗微生物活性,并且可用作治疗感染的药物 人或动物,或消毒剂。
-
-
-
-
-
-
-
-
-